Therapeutic Targeting

of the endocannabinoid system The endocannabinoid system is a physiological system composed of endocannabinoids, which are lipid-based molecules naturally produced by the body, and cannabinoid receptors, which are proteins found on the surface of cells. It is involved in regulating many physiological processes, including pain, mood, appetite, and the immune system. Targeting this system therapeutically has been studied to potentially treat a variety of conditions and diseases, including chronic pain, epilepsy, gastrointestinal issues, and diseases associated with an overactive immune system. In particular, the endocannabinoid system is being explored as a potential target in the treatment of cancer and mental health conditions such as anxiety and depression. Therapeutic targeting of the endocannabinoid system may provide a safe and effective treatment option for a wide range of conditions.